Black Diamond Therapeutics, Inc. Common Stock
BDTX •
Buy Open
Signal type
Buy
Status
Open
Open Price
$2.55
Stop Loss
$2.03
Performance
4.31%
Days Open
9
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 6, 2026
Open Price $2.55
Stop Loss $2.03
Timespan Day
Company Profile
Name Black Diamond Therapeutics, Inc. Common Stock
Ticker BDTX
Market Cap $141.02M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $2.66
List Date Jan 30, 2020
Description
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Website Open Company Website